Despite Merck KGaA’s lupus drug failing to prove itself against one form of the autoimmune disease, the German drugmaker has ...

Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025α7 nicotinic ...

People need healthcare products and services regardless of what's happening with the economy. Which healthcare stocks could ...

AstraZeneca AZN stock has declined 6.4% in the past three months. Although AstraZeneca faces its share of challenges, a ...

Just before dawn in Taicang, a county-level city in East China's Suzhou, Jiangsu province, hot dough at Brotecke — a beloved ...

Antimicrobial-resistant (AMR) “superbugs” contribute to more than 4.5 million deaths globally per year and threaten to make ...

The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...

Seek AI, the trusted AI agent platform for data, today announced that Vicci Eyewear has selected the Seek AI platform to power its data strategy for online retail growth. Vicci Eyewear, a Miami-based ...

The AltStar Awards, celebrating its fourteenth year as the premier recognition event for alternative culture, announces its 2025 event schedule including the third annual AltStar Expo featuring an all ...

Pfizer has the FDA approval it was seeking for Prevnar 20, the latest update to its blockbuster pneumococcal vaccination franchise, keeping it one step ahead of a competing shot from Merck & Co.

Amgen’s AMGN stock has declined 10.4% in the past three months. A lot of this price decline is related to the broader ...

The deal comes three months after Pfizer inked a PD-1/VEGF partnership with Summit Therapeutics, leading BMO Capital Markets ...